About one third of a million more people showed up at the ballot box in the United States in 2010 because of a single Facebook message on Election Day, estimates a new study led by the University of California, San Diego.
Structural and mechanical engineers at the University of California, San Diego, are working together to create blood flow simulations that could lead to improvements in the design of a cardiac pump for children born with heart defects. They hope that the design changes will improve young patients' outcomes.
The governing board of the California Institute for Regenerative Medicine (CIRM) has announced that six investigators from the University of California, San Diego Stem Cell Research program have received a total of more than $7 million in the latest round of CIRM funding. This brings UC San Diego’s total to more than $128 million in CIRM funding since the first awards in 2006.
An international team of researchers, led by scientists at the University of California, San Diego and Yale University schools of medicine, have identified a form of autism with epilepsy that may potentially be treatable with a common nutritional supplement.
Enzo Ocio, a premature baby born 1 pound, 10 ounces at only 25 weeks, spent four and a half months in the Neonatal Intensive Care Unit (NICU) at the University of California, San Diego Health System in Hillcrest. He was put on life support, suffered from multiple infections and struggled to eat on his own without the help of a feeding tube.
A study led by researchers at the UC San Diego Stem Cell Research program and funded by the California Institute for Regenerative Medicine (CIRM) looks at an important RNA binding protein called LIN28, which is implicated in pluripotency and reprogramming as well as in cancer and other diseases. According to the researchers, their study – published in the September 6 online issue of Molecular Cell – will change how scientists view this protein and its impact on human disease.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
